Cytokinetics, Incorporated CYTK
64.66
(1.00)
(1.52%)
as of 25 Sep
- Market cap
- $9.0B
- P/E
- 0.0×
Follow CYTK
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 32.63 |
P/S ratio |
86.68 | 285.13 | 1,078.30 | 42.12 | 49.76 | 24.02 | 22.74 | 10.92 | 32.34 | 4.65 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.98 |
P/Operating CF |
(53.50) | (80.33) | (109.67) | (40.57) | (78.33) | 25.71 | (32.06) | (27.90) | (17.96) | 6.36 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 14.37 | 11.83 | 0.00 | 13.26 | 3.94 | 5.25 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 14.37 | 11.83 | 0.00 | 13.26 | 3.94 | 5.25 |
EV/Sales |
89.80 | 262.46 | 1,078.65 | 40.30 | 45.30 | 18.19 | 19.34 | 5.96 | 15.34 | 3.47 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.99 |
EV/Operating CF |
(15.50) | (12.25) | (19.60) | (12.73) | (22.39) | 113.52 | (5.72) | (1.85) | (2.01) | 9.98 |
EV/FCF |
(14.78) | (12.13) | (19.54) | (12.26) | (16.67) | (481.39) | (5.56) | (1.84) | (1.96) | 10.42 |
Quick Ratio |
4.45 | 6.08 | 6.00 | 9.25 | 7.28 | 15.02 | 8.85 | 9.05 | 8.32 | 4.70 |
Current Ratio |
4.53 | 6.17 | 6.12 | 9.40 | 7.45 | 15.20 | 8.98 | 9.36 | 8.45 | 4.77 |
Net Debt/EBITDA |
(0.46) | 0.80 | (0.01) | 0.54 | 1.71 | 3.53 | 0.93 | 1.78 | 2.13 | (6.50) |
Debt/Assets |
81.23% | 46.88% | 74.90% | 60.17% | 18.76% | 25.99% | 46.33% | 20.08% | 10.78% | 17.56% |
Debt/Equity |
(1.75) | (4.85) | (1.60) | (5.66) | 0.65 | 1.22 | (12.28) | 1.64 | 0.29 | 0.32 |
Asset Turnover |
0.06 | 0.02 | 0.01 | 0.10 | 0.10 | 0.14 | 0.11 | 0.12 | 0.06 | 0.75 |
Operating CF/Net income |
0.65 | 0.67 | 0.79 | 0.77 | 0.66 | (0.07) | 0.75 | 0.95 | 0.80 | 2.25 |
Capex/Depreciation |
(2.45) | (0.41) | (0.12) | (1.95) | (21.47) | (6.04) | (2.03) | (0.71) | (1.50) | (2.11) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 197.47% | 226.00% | 212.96% | (572.15%) | (120.54%) | (248.50%) | (1,622.88%) | (156.57%) | (125.16%) | 20.19% | |
| (55.55%) | (52.97%) | (57.23%) | (41.91%) | (31.32%) | (30.91%) | (48.58%) | (42.01%) | (54.97%) | 11.53% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(98.90%) | (59.30%) | (88.58%) | (49.17%) | (40.09%) | (27.89%) | (57.33%) | (56.33%) | (52.07%) | 12.75% |
Average Days of Receivables |
73.65 | 328.96 | 62.19 | 0.57 | 268.56 | 28.90 | 70.14 | 25.85 | 30.36 | 0.08 |
Research and Development Expense of Revenue |
472.55% | 1,837.22% | 4,384.10% | 254.59% | 227.09% | 173.66% | 320.55% | 282.96% | 675.46% | 56.29% |
Selling, General and Administrative Expense of Revenue |
322.89% | 1,165.50% | 2,305.60% | 188.16% | 137.45% | 94.61% | 147.42% | 99.30% | 272.80% | 26.15% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
127.54% | 529.61% | 957.04% | 50.59% | 38.10% | 31.56% | 40.04% | 30.99% | 67.53% | 6.72% |
Graham Net Nets |
(0.15) | (0.08) | (0.07) | (0.08) | (0.02) | 0.04 | (0.11) | 0.07 | 0.21 | 0.17 |
Graham Number |
28.41 | 11.96 | 22.15 | 10.72 | 0.00 | 0.00 | 3.01 | 0.00 | 0.00 | 4.49 |
Earnings Yield |
(10.28%) | (11.18%) | (6.48%) | (9.58%) | (6.21%) | (9.67%) | (19.98%) | (30.85%) | (29.37%) | 3.06% |
Free Cash Flow Yield |
(7.01%) | (7.59%) | (5.12%) | (7.80%) | (5.46%) | (0.16%) | (15.31%) | (29.68%) | (24.21%) | 7.15% |
Revenue per Share |
0.73 | 0.17 | 0.08 | 1.05 | 0.92 | 0.87 | 0.47 | 0.58 | 0.27 | 2.66 |
Operating CF per Share |
(4.25) | (3.54) | (4.29) | (3.33) | (1.85) | 0.14 | (1.58) | (1.86) | (2.06) | 0.93 |
Capex per Share |
(0.21) | (0.03) | (0.01) | (0.13) | (0.64) | (0.17) | (0.05) | (0.02) | (0.06) | (0.04) |
Free Cash Flow per Share |
(4.45) | (3.57) | (4.31) | (3.46) | (2.49) | (0.03) | (1.62) | (1.88) | (2.12) | 0.89 |
Cash per Share |
7.35 | 9.61 | 6.37 | 8.71 | 6.13 | 7.19 | 3.91 | 3.65 | 5.44 | 3.91 |
Shareholders Equity per Share |
(5.49) | (1.21) | (4.00) | (1.20) | 3.17 | 1.76 | (0.19) | 0.48 | 2.22 | 2.36 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(5.49) | (1.21) | (4.00) | (1.20) | 3.17 | 1.76 | (0.19) | 0.48 | 2.22 | 2.36 |
Free Cash Flow |
(534.82) | (399.80) | (415.75) | (310.85) | (191.39) | (2.11) | (93.53) | (102.09) | (104.64) | 35.42 |
Working Capital |
714.52 | 928.27 | 525.37 | 710.57 | 463.81 | 443.02 | 207.73 | 185.48 | 241.85 | 125.38 |
Capital Expenditures |
(24.81) | (3.91) | (1.42) | (11.33) | (48.87) | (11.05) | (2.62) | (0.87) | (2.88) | (1.56) |
Net Current Asset Value |
(1,167.19) | (429.10) | (582.59) | (327.49) | (61.78) | 53.80 | (67.00) | 22.43 | 89.33 | 82.85 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19.74 |
Capex to Sales |
0.28 | 0.21 | 0.19 | 0.12 | 0.69 | 0.20 | 0.10 | 0.03 | 0.22 | 0.01 |
Net Profit Margin |
(891.60%) | (3,191.11%) | (6,988.63%) | (411.21%) | (305.72%) | (228.00%) | (452.93%) | (337.41%) | (955.94%) | 15.46% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 26.50 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.13 | 0.14 | 0.17 | 0.07 | 0.03 | 0.14 | 0.29 | 0.39 | 0.54 | 0.20 |
Cash ROIC |
(42.70%) | (28.90%) | (57.10%) | (29.56%) | (24.71%) | (0.61%) | (27.39%) | (39.10%) | (25.66%) | 11.89% |
Accounts Receivable Turnover |
5.12 | 2.06 | 10.53 | 3.64 | 2.50 | 11.65 | 7.27 | 18.85 | 23.54 | 5,911.50 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Receivables |
17.21 | 8.97 | 0.72 | 25.98 | 28.12 | 4.79 | 3.70 | 1.67 | 0.57 | 0.02 |
Average Payables |
21.35 | 20.94 | 23.56 | 23.35 | 14.57 | 8.11 | 5.96 | 4.51 | 4.74 | 3.24 |
Average Assets |
1,413.11 | 1,112.99 | 919.55 | 928.05 | 687.56 | 411.81 | 250.50 | 252.99 | 232.48 | 142.69 |
Average Common Equity |
(397.50) | (260.85) | (247.11) | 67.98 | 178.62 | 51.22 | 7.50 | 67.89 | 102.10 | 81.48 |
Columns are period end dates